For 50 years, CES has been the launch pad for new innovation and technology that has changed the world. Held in Las Vegas every year, it is the world’s gathering place for all who thrive on the business of consumer technologies and where next-generation innovations are introduced to the marketplace.
“We are incredibly honored to be selected for this prestigious award,” said Erez Gavish, 2breathe Technologies’ co-founder and CEO, “Recognition by the Consumer Technology Association also further validates the importance of addressing sleeplessness as part the next biotech and fitness frontier.”
2breathe induces sleep via guided breathing using a full-pattern Bluetooth respiration sensor and patented real-time coaching technology. Guiding tones composed from the user’s breathing prolong exhalation to reduce neural sympathetic activity and induce sleep. A detailed session report shows users the number of breaths taken, how well they followed the tones and when they fell asleep.
The underlying technology for 2breathe is based on the founders’ first product, RESPeRATE. Invented by Mr Gavish and his father, scientist Dr. Benjamin Gavish, RESPeRATE is also the world’s only FDA-cleared non-drug hypertension treatment device. When 90% of RESPeRATE users reported an improvement in sleep, they decided to adopt the guided-breathing technology onto a smartphone and created the 2breathe Sleep Inducer solution.
“164 million Americans struggle with sleep at least once a week,” said Mr. Gavish, “While this is not terribly surprising given modern day work schedules and life stresses, it’s an urgent problem given the significant toll sleeplessness has our health. Our goal at 2breathe is to help people find relief by actually inducing sleep through the ancient wisdom of guided breathing so they can get the rest they need.”
We are, of course, very honored and grateful and hope that this distinction allows us to bring the gift of a good night’s sleep to more of those who suffer from insomnia.